[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100606707":3},{"organization":4,"outcomesModule":7,"designInfo":21,"detailedDescription":20,"studyPopulation":20,"armGroups":32,"interventions":43,"overallOfficials":20,"centralContacts":52,"locations":57,"responsibleParty":119,"collaborators":20,"id":121,"slug":20,"hasResults":122,"nctId":123,"briefTitle":124,"officialTitle":125,"acronym":20,"eligibilityCriteria":126,"healthyVolunteers":122,"sex":127,"minAge":128,"maxAge":20,"enrollmentInfo":129,"targetDuration":20,"studyType":132,"phases":133,"briefSummary":135,"conditions":136,"keywords":20,"overallStatus":60,"whyStopped":20,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":147},{"fullName":5,"class":6},"Vanda Pharmaceuticals","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":20},[9],{"measure":10,"description":11,"timeFrame":12},"Corneal Staining","Corneal Staining will be assessed by the investigator on a scale of 0-4, with a higher number indicating a higher grade of staining.","Measured over an 8-week treatment period",[14,17],{"measure":15,"description":16,"timeFrame":12},"Schirmer's Tear Test","Schirmer tear test strips are used to measure ocular fluid.",{"measure":18,"description":19,"timeFrame":12},"Eye Dryness Score (EDS) of the Visual Analogue Scale (VAS)","EDS is reported by the subject using a 100-point scale (0=no discomfort and 100=maximum discomfort).",null,{"allocation":22,"interventionModel":23,"interventionModelDescription":20,"primaryPurpose":24,"observationalModel":20,"timePerspective":20,"maskingInfo":25},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":26,"maskingDescription":20,"whoMasked":27},"QUADRUPLE",[28,29,30,31],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[33,38],{"label":34,"type":35,"description":20,"interventionNames":36},"VSJ-110 Solution","EXPERIMENTAL",[37],"Drug: VSJ-110",{"label":39,"type":40,"description":20,"interventionNames":41},"Placebo Solution","PLACEBO_COMPARATOR",[42],"Drug: Placebo",[44,49],{"type":45,"name":46,"description":47,"armGroupLabels":48,"otherNames":20},"DRUG","VSJ-110","ophthalmic solution",[34],{"type":45,"name":50,"description":47,"armGroupLabels":51,"otherNames":20},"Placebo",[39],[53],{"name":5,"role":54,"phone":55,"phoneExt":20,"email":56},"CONTACT","202-734-3400","clinicaltrials@vandapharma.com",[58,74,86,97,108],{"facility":59,"status":60,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":71,"contacts":72},"Vanda Investigational Site","RECRUITING","Newport Beach","California","92663","United States","US",{"type":67,"coordinates":68},"Point",[69,70],-117.92895,33.61891,{"lat":70,"lon":69},[73],{"name":5,"role":54,"phone":55,"phoneExt":20,"email":20},{"facility":59,"status":75,"city":76,"state":77,"zip":78,"country":64,"countryCode":65,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"NOT_YET_RECRUITING","Andover","Massachusetts","01810",{"type":67,"coordinates":80},[81,82],-71.137,42.65843,{"lat":82,"lon":81},[85],{"name":5,"role":54,"phone":55,"phoneExt":20,"email":20},{"facility":59,"status":75,"city":87,"state":88,"zip":89,"country":64,"countryCode":65,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"Shelby","North Carolina","28150",{"type":67,"coordinates":91},[92,93],-81.53565,35.29235,{"lat":93,"lon":92},[96],{"name":5,"role":54,"phone":55,"phoneExt":20,"email":20},{"facility":59,"status":60,"city":98,"state":99,"zip":100,"country":64,"countryCode":65,"cosmosGeoPoint":101,"geoPoint":105,"contacts":106},"Memphis","Tennessee","38119",{"type":67,"coordinates":102},[103,104],-90.04898,35.14953,{"lat":104,"lon":103},[107],{"name":5,"role":54,"phone":55,"phoneExt":20,"email":20},{"facility":59,"status":75,"city":109,"state":110,"zip":111,"country":64,"countryCode":65,"cosmosGeoPoint":112,"geoPoint":116,"contacts":117},"Lynchburg","Virginia","24502",{"type":67,"coordinates":113},[114,115],-79.14225,37.41375,{"lat":115,"lon":114},[118],{"name":5,"role":54,"phone":55,"phoneExt":20,"email":20},{"type":120,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100606707",false,"NCT07179055","An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye","An Eight-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye","Inclusion Criteria:\n\n* Be at least 18 years of age of either gender and any race.\n* Provide written informed consent and sign the HIPAA form.\n* Be willing and able to follow all instructions and attend all study visits.\n\nExclusion Criteria:\n\n* Use of any of the disallowed medications during the washout and study period.","ALL","18 Years",{"count":130,"type":131},160,"ESTIMATED","INTERVENTIONAL",[134],"PHASE2","The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.",[137],"Dry Eye","2025-09-10",{"date":140,"type":141},"2025-09-17","ACTUAL",{"date":143,"type":131},"2025-10",{"date":145,"type":131},"2026-09",{"name":5,"class":6},5]